Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Borsa-Lebas

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Antimicrobial Agents and Chemotherapy|December 1, 1992
Pharmacokinetics of meropenem (ICI 194,660) and its metabolite (ICI 213,689) in healthy subjects and in patients with renal impairmentA Leroy, J P Fillastre, F Borsa-Lebas, et al.
Drugs Under Experimental and Clinical Research|January 1, 1992
Effects of ketoprofen (NSAID) on the pharmacokinetics of pefloxacin and ofloxacin in healthy volunteersJ P Fillastre, A Leroy, F Borsa-Lebas, et al.
Clinical and Experimental Immunology|February 1, 1995
Comparison of activation marker and TCR V beta gene product expression by CD4+ and CD8+ T cells in peripheral blood and lymph nodes from HIV-infected patientsS Ramzaoui, F Jouen-Beades, F Michot, et al.
Clinical Immunology and Immunopathology|May 1, 1996
Similarity of expression of activation markers and CD28 on gamma delta and alpha beta-receptor T cells in HIV infectionF Jouen-Beades, D Gilbert, S Ramzaoui, et al.
Pathologie-Biologie|April 1, 1993
[Effect of ketoprofen on the pharmacokinetics of two fluoroquinolones in males]A Leroy, J P Fillastre, F Borsa-Lebas, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1990
Pharmacokinetics of quinolones in renal insufficiencyJ P Fillastre, A Leroy, B Moulin, et al.
Clinical Immunology and Immunopathology|October 1, 1995
During HIV infection, CD4+ CD38+ T-cells are the predominant circulating CD4+ subset whose HLA-DR positivity increases with disease progression and whose V beta repertoire is similar to that of CD4+ CD38- T-cellsS Ramzaoui, F Jouen-Beades, D Gilbert, et al.
Clinical Pharmacology and Therapeutics|December 1, 1991
Influence of rifampin on the pharmacokinetics of pefloxacinG Humbert, I Brumpt, G Montay, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 22, 2001
Successful treatment of metronidazole- and albendazole-resistant giardiasis with nitazoxanide in a patient with acquired immunodeficiency syndromeP Abboud, V Lemée, G Gargala, et al.
Journal of Acquired Immune Deficiency Syndromes|May 1, 1994
Trimethoprim-sulfamethoxazole versus aerosolized pentamidine for primary prophylaxis of Pneumocystis carinii pneumonia: a prospective, randomized, controlled clinical trial. LFPMI Study Group. Ligue Française de Prévention des Maladies InfectieusesT May, C Beuscart, J Reynes, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Antimicrobial Agents and Chemotherapy|December 1, 1992
Pharmacokinetics of meropenem (ICI 194,660) and its metabolite (ICI 213,689) in healthy subjects and in patients with renal impairmentA Leroy, J P Fillastre, F Borsa-Lebas, et al.
Drugs Under Experimental and Clinical Research|January 1, 1992
Effects of ketoprofen (NSAID) on the pharmacokinetics of pefloxacin and ofloxacin in healthy volunteersJ P Fillastre, A Leroy, F Borsa-Lebas, et al.
Clinical and Experimental Immunology|February 1, 1995
Comparison of activation marker and TCR V beta gene product expression by CD4+ and CD8+ T cells in peripheral blood and lymph nodes from HIV-infected patientsS Ramzaoui, F Jouen-Beades, F Michot, et al.
Clinical Immunology and Immunopathology|May 1, 1996
Similarity of expression of activation markers and CD28 on gamma delta and alpha beta-receptor T cells in HIV infectionF Jouen-Beades, D Gilbert, S Ramzaoui, et al.
Pathologie-Biologie|April 1, 1993
[Effect of ketoprofen on the pharmacokinetics of two fluoroquinolones in males]A Leroy, J P Fillastre, F Borsa-Lebas, et al.
The Journal of Antimicrobial Chemotherapy|October 1, 1990
Pharmacokinetics of quinolones in renal insufficiencyJ P Fillastre, A Leroy, B Moulin, et al.
Clinical Immunology and Immunopathology|October 1, 1995
During HIV infection, CD4+ CD38+ T-cells are the predominant circulating CD4+ subset whose HLA-DR positivity increases with disease progression and whose V beta repertoire is similar to that of CD4+ CD38- T-cellsS Ramzaoui, F Jouen-Beades, D Gilbert, et al.
Clinical Pharmacology and Therapeutics|December 1, 1991
Influence of rifampin on the pharmacokinetics of pefloxacinG Humbert, I Brumpt, G Montay, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 22, 2001
Successful treatment of metronidazole- and albendazole-resistant giardiasis with nitazoxanide in a patient with acquired immunodeficiency syndromeP Abboud, V Lemée, G Gargala, et al.
Journal of Acquired Immune Deficiency Syndromes|May 1, 1994
Trimethoprim-sulfamethoxazole versus aerosolized pentamidine for primary prophylaxis of Pneumocystis carinii pneumonia: a prospective, randomized, controlled clinical trial. LFPMI Study Group. Ligue Française de Prévention des Maladies InfectieusesT May, C Beuscart, J Reynes, et al.
Pageof 2